Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04652869
Other study ID # STUDY19110132
Secondary ID 1R21AG064361
Status Completed
Phase N/A
First received
Last updated
Start date May 21, 2021
Est. completion date February 10, 2023

Study information

Verified date February 2023
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Urge urinary incontinence (UUI) is a common problem in older women, which vastly reduces quality of life. UUI sufferers frequently report situational triggers (e.g. approaching the front door) leading to urinary urgency and/or leakage, which can be caused by psychological conditioning. This project will test the feasibility, acceptability, and efficacy of brief mindfulness (MI) and non-invasive brain stimulation (transcranial direct current stimulation; tDCS) to reduce reactivity to personal urgency cues and attenuate symptoms of UUI. This is a novel step towards providing personalized efficacious non-pharmacologic treatment for UUI.


Description:

Urinary urgency incontinence (UUI) is a highly prevalent, morbid and costly (up to $83 billion/year) disorder among older women, with up to 36% of those over 65 afflicted. One commonly experienced phenomenon among those with UUI is conditioned bladder responses to external triggers, often labeled "situational incontinence." Situational incontinence is described by sufferers as urinary urgency and leakage when confronted with specific contextual triggers or cues, such as approaching the front/garage door 'latch-key incontinence', and exposure to running water such as doing dishes. Generally ascribed to 'bladder spasms' (detrusor overactivity), studies have revealed that anywhere between 42% and 80% of women with UUI experience situationally provoked urgency, with approximately 26% of those experiencing situationally triggered leakage. The researchers recent work has focused on developing methods to recreate exposure to individuals' situational urgency cues, testing the impact of "urgency" and "safe" cues on self-report urgency and actual leakage, and finally assessing the role of bladder control mechanisms in the brain in response to these personal situational cues. The researchers found that women with situational UUI experienced increased urgency and leakage when exposed to personal "urgency" versus "safe" photographic cues from their daily lives. Further, brain areas related to attentional and visuospatial processing were activated during exposure to urge, but not safe, cues. Past studies of urgency simulated by bladder filling, show that prefrontal cortex, a seat of executive control, is activated to aid in controlling bladder activation. However, the study found that the PFC was not recruited during exposure to visual cues among women with situational urgency. Thus, the researchers propose that interventions capable of enhancing PFC activation during exposure to urgency situations should enable women to gain executive control over cues and result in less cue-provoked urgency and leakage, as well as overall UUI symptomatology. Using these now well-tested methods to personalize stimuli with photographs of urgency-provoking situational cues, the goal is to test the feasibility, acceptability, and compliance of these promising methods to attenuate urgency-related reactivity and reduce UUI symptoms. These novel methods include: (1) Brief mindfulness (MI) focused on body scan and acceptance language, (2) Transcranial direct current stimulation (tDCS) applied to the dorsolateral PFC, and (3) a combination of MI + tDCS. Sixty women with situational UUI will be randomized into a 7-session study, with a mail-in follow up 1-week post-training. All participants will undergo 4 urgency-cue exposure training sessions during which they will engage in one of the three interventions, based on group. Changes in urgency will be assessed via pre-post training differences in: Cue-reactivity to personal urge and safe cues, reaction time to a urinary Stroop task, self-report severity of bladder problems, and UUI episodes and urgency ratings on a daily bladder diary. Attenuating reactivity to situational urgency cues will increase our ability to complement and enhance the efficacy of UUI therapy and reduce symptom burden for its many sufferers.


Recruitment information / eligibility

Status Completed
Enrollment 121
Est. completion date February 10, 2023
Est. primary completion date February 3, 2023
Accepts healthy volunteers No
Gender Female
Age group 40 Years and older
Eligibility Inclusion Criteria: - Female; 40+ years old - Self-report situational urgency in at least 4 of 15 common scenarios - At least 2 leaks/week - Urge Urinary Incontinence symptomatology bother score =4 Exclusion Criteria: - Cognitive impairment (inability to complete tasks) as measured by an MoCA < 26 - Urinary retention (PVR>200ml) - Interstitial cystitis - Spinal cord injury - Pelvic irradiation or other cause of pelvic nerve damage - Active urinary tract infection (UTI)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Transcranial direct current stimulation
Transcranial direct current stimulation targeting the dorsolateral prefrontal cortex
Behavioral:
Mindfulness
Mindfulness is a type of meditation in which you focus on being intensely aware of what you're sensing and feeling in the moment, without interpretation or judgment.

Locations

Country Name City State
United States University of Pittsburgh Pittsburgh Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
Cynthia Conklin National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of study procedures measured by percentage of enrolled participants who complete the study 4-weeks
Primary Acceptability of study procedures measured by 8-item with a 0-100 scale on the Post-Study Survey. A higher score indicates greater acceptability. 4-weeks
Primary Compliance with study procedures measured by 2-items with a 0-100 scale on the Post-Study Survey. A higher score indicates greater compliance 4-weeks
Primary Change from baseline in cue-induced reactivity to personal photographic urge cues as measured by a 8-item 0-100 scale questionnaire. A higher score indicates greater cue-reactivity Baseline to 1 week
Primary Reaction time to Urinary Stroop Task Change in reaction time to words associated with urgency Baseline to 1 week
Primary Change from baseline in severity of bladder problem measured by the ICIQ-FLUTS a 12-item questionnaire evaluating urinary tract symptoms and impact on quality of life. A higher score indicates greater symptoms and greater impact on quality of life. Baseline to 1 week
Primary Urge Urinary Incontinence (UUI) Incidence Change in the number of UUI Incidences Baseline to 1 week
Secondary Treatment Change Treatment change will be examined by plotting the slope and linearity of daily bladder diary and urgency survey data 4 weeks
Secondary Individual Differences as measured by age, years of UUI and baseline measures as moderators of the efficacy of the intervention 4 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06201013 - Efficacy and Safety of Vitamin D in the Treatment of OAB-wet in Children N/A
Completed NCT02001714 - Group Learning Achieves Decreased Incidents of Lower Urinary Symptoms N/A
Not yet recruiting NCT00523068 - Pharmacological vs Surgical Treatment for Mixed Incontinence Phase 4
Enrolling by invitation NCT05404386 - Effect of Mobile Application on Urinary Incontinence N/A
Recruiting NCT05362292 - TReating Incontinence for Underlying Mental and Physical Health Phase 4
Completed NCT01959347 - Combined Treatment for Mixed Incontinence Phase 3
Recruiting NCT04271852 - An Experimental Protocol for the Study of Brain Functional Magnetic Resonance Imaging in Female With Urgent Urinary Incontinence N/A
Completed NCT01971437 - Cystoscopy and Cystodistension; Therapeutic and Aetiological Aspect in Overactive Bladder N/A
Terminated NCT01464372 - Electromagnetic Stimulation for the Treatment of Urge Urinary Incontinence and Overactive Bladder Phase 3
Completed NCT04528784 - Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis N/A
Recruiting NCT05874375 - UCon Treatment of Overactive Bladder (OAB) in Males N/A
Recruiting NCT05735522 - Effectiveness of Magnetic Stimulation in the Treatment of Female UUI. N/A
Active, not recruiting NCT03327948 - Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt N/A
Completed NCT03543566 - Bladder Antimuscarinic Medication and Accidental Bowel Leakage
Not yet recruiting NCT06336304 - NXT Post-Market Clinical Follow-up
Completed NCT01110278 - Examining Bladder Control Using Magnetic Resonance Imaging (MRI) and Diffusion Tensor Imaging (DTI) N/A
Active, not recruiting NCT05308979 - Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial Phase 4
Recruiting NCT05250908 - INTIBIA Pivotal Study N/A
Withdrawn NCT02434874 - Sacral Nerve Stimulation to Treat Urgency Urinary Incontinence With Wireless Neuromodulation N/A
Completed NCT04024085 - Time to be Ready to Void: a New Tool to Assess the Time Needed to Perform Micturition in Multiple Sclerosis